The allocation of multinational business income : reassessing the formulary apportionment option

John Azzi

The allocation of multinational business income : reassessing the formulary apportionment option

Research output: Contribution to journal › Article › peer-review

Abstract

Book review - The Allocation of Multinational Business Income: Reassessing the Formulary Apportionment Option, by Richard Krever and FranÃ§ois Vaillancourt (eds), Wolters Kluwer, 2020, 368pp. ISBN:9403506148/9789403506142

Original language	English
Pages (from-to)	142-147
Number of pages	6
Journal	Australian Tax Review
Volume	50
Publication status	Published - 2021

Cite this

@article{38a38706c47b4286895c13ac403e1d88,

title = "The allocation of multinational business income : reassessing the formulary apportionment option",

abstract = "Book review - The Allocation of Multinational Business Income: Reassessing the Formulary Apportionment Option, by Richard Krever and Fran{\~A}§ois Vaillancourt (eds), Wolters Kluwer, 2020, 368pp. ISBN:9403506148/9789403506142",

author = "John Azzi",

year = "2021",

language = "English",

volume = "50",

pages = "142--147",

journal = "Australian Tax Review",

issn = "0311-094X",

publisher = "Lawbook Co",

}

TY - JOUR

T1 - The allocation of multinational business income : reassessing the formulary apportionment option

AU - Azzi, John

PY - 2021

Y1 - 2021

N2 - Book review - The Allocation of Multinational Business Income: Reassessing the Formulary Apportionment Option, by Richard Krever and FranÃ§ois Vaillancourt (eds), Wolters Kluwer, 2020, 368pp. ISBN:9403506148/9789403506142

AB - Book review - The Allocation of Multinational Business Income: Reassessing the Formulary Apportionment Option, by Richard Krever and FranÃ§ois Vaillancourt (eds), Wolters Kluwer, 2020, 368pp. ISBN:9403506148/9789403506142

UR - https://hdl.handle.net/1959.7/uws:61508

M3 - Article

SN - 0311-094X

VL - 50

SP - 142

EP - 147

JO - Australian Tax Review

JF - Australian Tax Review

ER -

The allocation of multinational business income : reassessing the formulary apportionment option

Abstract

Other files and links

Fingerprint

Cite this